GlassScriptPhysician profile
Mai T Vu
NPI 1700049582
$2,876.93
in general payments reported to CMS, 2019-2025
37 companies · $504 in 2025
The $504 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $325 · 2021: $539 · 2022: $502 · 2023: $379 · 2024: $426 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,308.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $477.17 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $437.12 | 2020-2025 | Cabtreo, Jublia, Arazlo |
| E.R. Squibb & Sons, L.L.C. | $182.91 | 2023-2025 | Sotyktu |
| Exeltis, USA INC. | $180.26 | 2019-2025 | Slynd |
| Sage Therapeutics, LLC | $128.62 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $125.93 | 2022-2025 | |
| Abbvie INC. | $113.33 | 2019-2023 | Lo Loestrin Fe |
| Gilead Sciences, INC. | $105.60 | 2020 | |
| Mayne Pharma Commercial LLC | $105.43 | 2023-2025 | |
| Dermavant Sciences, INC. | $92.54 | 2023 | Vtama |
| Genzyme Corporation | $89.13 | 2022 | |
| Sumitomo Pharma America, INC. | $83.89 | 2024-2025 | Myfembree |
| Exact Sciences Corporation | $66.40 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $64.42 | 2020-2023 | |
| Therapeuticsmd, INC. | $56.95 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $45.09 | 2024 | |
| Astellas Pharma US INC | $42.17 | 2024 | Myrbetriq, Veozah |
| Medtronic, INC. | $40.53 | 2025 | V-Loc 180 |
| Hologic Sales and Service, LLC | $40.52 | 2019-2024 | Aptima, Thinprep 2000 Processor |
| Amag Pharmaceuticals, INC. | $39.83 | 2019 | |
| Sun Pharmaceutical Industries INC. | $37.20 | 2020 | |
| Lupin INC. | $36.56 | 2019 | |
| Coopersurgical, INC. | $34.05 | 2022-2024 | Paragard T 380a |
| Teva Pharmaceuticals USA, INC. | $29.87 | 2019-2020 | |
| Meditrina | $22.33 | 2023 | |
| Glaxosmithkline, LLC. | $20.70 | 2025 | Arexvy, Trelegy Ellipta |
| Medicem INC. | $20.67 | 2020 | |
| Aspira Women'S Health INC | $19.90 | 2024 | Ova1 |
| Journey Medical Corporation | $19.56 | 2024 | |
| Evofem Biosciences, INC. | $19.05 | 2021 | |
| Allergan, INC. | $17.05 | 2019 | |
| Currax Pharmaceuticals LLC | $15.81 | 2025 | Contrave |
| Renovia INC | $14.20 | 2020 | |
| Ascensia Diabetes Care US INC. | $13.73 | 2025 | |
| Convatec INC. | $13.71 | 2022 | |
| Idorsia Pharmaceuticals US INC | $13.64 | 2024 | Quviviq |
| Minerva Surgical, INC | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mai Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.